SCHEMBL30946437

SCHEMBL30946437

Cc1cn(-c2cc(N)ccc2C(F)(F)F)nn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 4/20 0.48
▸ LRRK2 Q5S007 1/20 0.43
▸ GLA P06280 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ STS P08842 1/20 0.36
▸ BRD4 O60885 1/20 0.35
▸ APP P05067 1/20 0.35
▸ KIF11 P52732 1/20 0.34
▸ TRPV1 Q8NER1 1/20 0.34
▸ AR P10275 1/20 0.33
▸ NR1H2 P55055 1/20 0.33
▸ P2RY14 Q15391 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31284267 0.82 NOTUM (0.48) NOTUMLRRK2STSBRD4APP
SCHEMBL18377889 0.78 NOTUM (0.52) NOTUMBRD4APPTRPV1ALDH1A1
SCHEMBL4020226 0.77 LRRK2 (0.46) NOTUMLRRK2BRD4ALDH1A1KDM4E
SCHEMBL31284763 0.77 TDO2 (0.45) GLAPOLBGAATSHRKIF11
SCHEMBL14320577 0.73 NOTUM (0.54) NOTUMGLAPOLBGAATSHR
SCHEMBL31284304 0.72 NOTUM (0.42) NOTUMLRRK2STSBRD4APP
SCHEMBL14036559 0.72 NR4A1 (0.54) NOTUMLRRK2GAATSHRBRD4
SCHEMBL20283634 0.71 KDM4E (0.49) NOTUMLRRK2GAABRD4ALDH1A1
SCHEMBL2059016 0.69 TSHR (0.56) GLAPOLBGAATSHRKIF11
SCHEMBL30750882 0.69 TSHR (0.56) GLAPOLBGAATSHRKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743085-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
EP-4634161-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Tenvie Therapeutics Inc. (US) 2025-10-22 — — EP disclosed
WO-2025019357-A2 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-01-23 — — WO disclosed
WO-2024130166-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-06-20 — — WO disclosed
Send feedback